MG53 transcriptionally upregulates peroxisome proliferation-activated receptor alpha and its target genes, resulting in diabetic cardiomyopathy, indicating complicated mechanisms underlying its biological effects [38]. The gene discussed is PPARA; the disease is diabetic cardiomyopathy.